-
PP 2 (AG 1879): Src Pathway Workflows
2026-09-24
Use PP 2 (AG 1879) to test how Src-family kinase activity contributes to cancer-cell behaviors, T-cell signaling, and cytoskeletal remodeling. This practical guide pairs potency-aware dosing with an assay framework for probing the PA–Src–FAK–RhoA/ROCK pathway in decidualization—without treating a research inhibitor as proof of pathway specificity.
-
Y-27632: Practical ROCK Inhibitor Workflow Guide
2026-09-24
Y-27632 is a ROCK inhibitor for experimentally probing ROCK1/ROCK2 signaling and actin stress-fiber organization in cultured cells. Use it to test defined cellular responses with vehicle and untreated controls; do not treat its effects as proof of pathway specificity in every model or use it for diagnostic or medical purposes.
-
PBS Liposomes and the Logic of Mechanistic Controls
2026-09-23
PBS Liposomes provide a matched negative control for clodronate-mediated macrophage depletion. This article explains what that comparison can establish, where its interpretation ends, and how it differs from molecular-resolution evidence such as structural studies of TRPM3.
-
Protease Inhibitor Cocktail for RA-FLS Protein Workflows
2026-09-23
Protect STAT1, TYK2, C3, and inflammatory protein readouts during RA-FLS lysis with a broad-spectrum cocktail plus optional EDTA. This workflow distinguishes protease control from phosphatase control and shows when EDTA removal is essential for kinase, IMAC, and two-dimensional gel workflows.
-
Non-Proteolytic Ubiquitination Tunes Rice Immunity
2026-09-22
This 2024 Nature Communications study identifies the RING E3 ligase IPI7 as a co-activator that enables phosphorylated IPA1 to activate WRKY45 during Magnaporthe oryzae infection. Its central advance is showing that K29-linked ubiquitination can tune transcription factor activity without destabilizing the substrate, separating immune activation from IPA1-dependent yield traits.
-
Vardenafil HCl Trihydrate: Assay Design Guide
2026-09-22
Vardenafil HCl Trihydrate supports a staged strategy that connects PDE5 inhibition assays with cGMP signaling and tissue-level smooth muscle relaxation research. This guide translates native proteoform findings into practical decisions for biochemical, functional, and off-target study design.
-
Dehydroabietic Acid: PPAR Workflow Guide
2026-09-21
Dehydroabietic acid is a practical dual PPAR-α/γ agonist for connecting receptor activation with lipid metabolism regulation and insulin sensitivity studies. This workflow also shows how to test, without overclaiming, whether PPAR-directed metabolic changes intersect with the WTAP–GLS ferroptosis-resistance axis reported in hepatocellular carcinoma.
-
Cyclosporin in Reliable Cell Assays
2026-09-21
This evidence-based guide explains how Cyclosporin, SKU B8309, can support interpretable cell viability, proliferation, and immunosuppression assays. It connects mechanism, concentration selection, controls, storage, and vendor evaluation while distinguishing product-dossier data from practical workflow recommendations.
-
Phosphatase Inhibitor Cocktail: Workflow Guide
2026-09-20
A practical guide to using a dual-tube Phosphatase Inhibitor Cocktail for phosphorylation-sensitive lysates, immunoblotting, kinase assays, immunoprecipitation, and mass spectrometry. The workflow emphasizes sequential addition, matrix-specific controls, and troubleshooting for samples such as injured brain tissue and activated microglia.
-
Amiloride (MK-870) Workflow for Ion Transport
2026-09-19
Amiloride (MK-870) is a practical dual-pathway probe for separating epithelial sodium channel, PC2, and uPAR-linked effects in cell and membrane assays. Its value is equally important as a mechanistic negative control: a reovirus entry study found that amiloride did not block infection, helping researchers distinguish sodium-channel modulation from clathrin-dependent endocytosis.
-
Miltefosine: A Context-Dependent Signaling Probe
2026-09-18
Miltefosine is a PI3K/Akt pathway modulator with context-dependent effects on cancer biology, metabolism, and neutrophil differentiation. This article explains how recent Ras/MEK/ERK findings should reshape assay design, pathway validation, and interpretation of Miltefosine experiments.
-
tFUS, SHP2, and NLRP3 After Ischemic Stroke
2026-09-18
This study links low-intensity transcranial focused ultrasound stimulation (tFUS) to reduced post-stroke neuroinflammation through the Nespas/miR-383-3p/SHP2 axis. Rat and BV2 microglial experiments indicate that SHP2 is an important downstream regulator of NLRP3 inflammasome activity, providing a mechanistic framework for studying noninvasive neuromodulation after ischemic injury.
-
β-TRCP1–OTUD3 Control of cGAS Activation
2026-09-17
A 2026 Journal of Biological Chemistry study identifies a β-TRCP1–RSK3 pathway that phosphorylates and destabilizes the deubiquitinase OTUD3, thereby controlling cGAS abundance and activity. Cytosolic DNA suppresses this turnover pathway through mTORC2-dependent signaling, revealing a conditional mechanism for tuning innate immune responses.
-
AS1842856 Foxo1 Inhibitor: Assay Workflows
2026-09-17
AS1842856 enables direct Foxo1 activity control for gluconeogenesis, autophagy, and pathway-dissection studies without requiring changes in Foxo1 abundance. This guide translates its biochemical profile and the KDM4D–PI3K–Akt–Foxo1 findings into practical workflows, controls, and troubleshooting decisions.
-
Okadaic acid: PP1/PP2A Workflow Guide
2026-09-16
Okadaic acid (SKU A4540) provides a controlled way to inhibit PP2A at low nanomolar potency and PP1 at higher concentrations in phosphorylation and apoptosis workflows. It is best used with vehicle, concentration, and phosphatase-specificity controls, and should not be treated as a universal apoptosis inducer or clinical model.